Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation von Shi, Jumei, Tricot, Guido, Szmania, Susann, Rosen, Nancy, Garg, Tarun K., Malaviarachchi, Priyangi A., Moreno, Amberly, DuPont, Bo, Hsu, Katharine C., Baxter‐Lowe, Lee Ann, Cottler‐Fox, Michele, Shaughnessy Jr, John D., Barlogie, Bart, Van Rhee, Frits

Volltext

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2 von Zhou, Yiming, Chen, Lijuan, Barlogie, Bart, Stephens, Owen, Wu, Xiaosong, Williams, David R, Cartron, Marie-Astrid, van Rhee, Frits, Nair, Bijay, Waheed, Sarah, Pineda-Roman, Mauricio, Alsayed, Yazan, Anaissie, Elias, Shaughnessy, John D. Jr

Volltext

Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway von Knobloch, Jürgen, Shaughnessy, John D. Jr, Rüther, Ulrich

Volltext

Variability of definition of high‐risk multiple myeloma across phase III clinical trials von Abu Za'nouneh, Faris Jamal, Ababneh, Obada, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., Zhan, Fenghuang, Rhee, Frits, Al Hadidi, Samer

Volltext

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma von Tian, Erming, Zhan, Fenghuang, Walker, Ronald, Rasmussen, Erik, Ma, Yupo, Barlogie, Bart, Shaughnessy, John D

Volltext

Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outco... von Mohan, Meera, Gong, Zimu, Ashby, Timothy Cody, Al Hadidi, Samer, Thanendrarajan, Sharmilan, Schinke, Carolina, Alapat, Daisy, Shaughnessy, John D., Zhan, Fenghuang, Rhee, Frits, Sawyer, Jeffery R., Tian, Erming, Zangari, Maurizio

Volltext

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions von Sun, Fumou, Cheng, Yan, Chen, Jin-Ran, Wanchai, Visanu, Mery, David E, Xu, Hongwei, Gai, Dongzheng, Al Hadidi, Samer, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits, Tricot, Guido, Shaughnessy, Jr, John D, Zhan, Fenghuang

Volltext

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma von Hsi, Eric D, Steinle, Roxanne, Balasa, Balaji, Szmania, Susann, Draksharapu, Aparna, Shum, Benny P, Huseni, Mahrukh, Powers, David, Nanisetti, Amulya, Zhang, Yin, Rice, Audie G, van Abbema, Anne, Wong, Melanie, Liu, Gao, Zhan, Fenghuang, Dillon, Myles, Chen, Shihao, Rhodes, Susan, Fuh, Franklin, Tsurushita, Naoya, Kumar, Shankar, Vexler, Vladimir, Shaughnessy, Jr, John D, Barlogie, Bart, van Rhee, Frits, Hussein, Mohamad, Afar, Daniel E H, Williams, Marna B

Volltext

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma von Mao, Xuehan, Yan, Wenqiang, Mery, David, Liu, Jiahui, Fan, Huishou, Xu, Jingyu, Xu, Yan, Sui, Weiwei, Deng, Shuhui, Zou, Dehui, Du, Chenxing, Yi, Shuhua, Rhee, Frits, Barlogie, Bart, Shaughnessy, John D., Anderson, Kenneth C., Zhan, Fenghuang, Qiu, Lugui, An, Gang

Volltext

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation von Gai, Dongzheng, Chen, Jin-Ran, Stewart, James P, Nookaew, Intawat, Habelhah, Hasem, Ashby, Cody, Sun, Fumou, Cheng, Yan, Li, Can, Xu, Hongwei, Peng, Bailu, Garg, Tarun K, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Chen, Fangping, Barlogie, Bart, van Rhee, Frits, Tricot, Guido, Shaughnessy Jr., John D, Zhan, Fenghuang

Volltext

Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications von WALKER, Ronald, BARLOGIE, Bart, CROWLEY, John, FERRIS, Ernest, HOLLMIG, Klaus, VAN RHEE, Frits, ZANGARI, Maurizio, PINEDA-ROMAN, Mauricio, MOHIUDDIN, Abid, YACCOBY, Shmuel, SAWYER, Jeffrey, ANGTUACO, Edgardo J, HAESSLER, Jeffrey, TRICOT, Guido, ANAISSIE, Elias, SHAUGHNESSY, John D, EPSTEIN, Joshua, VAN HEMERT, Rudy, ERDEM, Eren, HOERING, Antje

Volltext

Heparanase Enhances Syndecan-1 Shedding: A NOVEL MECHANISM FOR STIMULATION OF TUMOR GROWTH AND METASTASIS von Yang, Yang, MacLeod, Veronica, Miao, Hua-Quan, Theus, Allison, Zhan, Fenghuang, Shaughnessy, John D. Jr, Sawyer, Jeffrey, Li, Jin-Ping, Zcharia, Eyal, Vlodavsky, Israel, Sanderson, Ralph D

Volltext

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma von HOSE, Dirk, REME, Thierry, HILLENGASS, Jens, BERTSCH, Uta, NEBEN, Kai, MÖHLER, Thomas, ROSSI, Jean Francois, JAUCH, Anna, KLEIN, Bernard, GOLDSCHMIDT, Hartmut, HIELSCHER, Thomas, MOREAUX, Jérôme, MESSNER, Tobias, SECKINGER, Anja, BENNER, Axel, SHAUGHNESSY, John D, BARLOGIE, Bart, YIMING ZHOU

Volltext

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3 von Barlogie, Bart, Anaissie, Elias, Van Rhee, Frits, Haessler, Jeffrey, Hollmig, Klaus, Pineda‐Roman, Mauricio, Cottler‐Fox, Michele, Mohiuddin, Abid, Alsayed, Yazan, Tricot, Guido, Bolejack, Vanessa, Zangari, Maurizio, Epstein, Joshua, Petty, Nathan, Steward, Douglas, Jenkins, Bonnie, Gurley, Jennifer, Sullivan, Ellen, Crowley, John, Shaughnessy, John D.

Volltext

Genetics and cytogenetics of multiple myeloma: a workshop report von Fonseca, Rafael, Barlogie, Bart, Bataille, Regis, Bastard, Christian, Bergsagel, P Leif, Chesi, Marta, Davies, Faith E, Drach, Johannes, Greipp, Philip R, Kirsch, Ilan R, Kuehl, W Michael, Hernandez, Jesus M, Minvielle, Stephane, Pilarski, Linda M, Shaughnessy, Jr, John D, Stewart, A Keith, Avet-Loiseau, Herve

Volltext

A gene signature can predict risk of MGUS progressing to multiple myeloma von Sun, Fumou, Cheng, Yan, Ying, Jun, Mery, David, Al Hadidi, Samer, Wanchai, Visanu, Siegel, Eric R, Xu, Hongwei, Gai, Dongzheng, Ashby, Timothy Cody, Bailey, Clyde, Chen, Jin-Ran, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Janz, Siegfried, Barlogie, Bart, Van Rhee, Frits, Tricot, Guido, Shaughnessy, Jr, John D, Zhan, Fenghuang

Volltext

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma von van Rhee, Frits, Szmania, Susann M, Dillon, Myles, van Abbema, Anne M, Li, Xin, Stone, Mary K, Garg, Tarun K, Shi, JuMei, Moreno-Bost, Amberly M, Yun, Rui, Balasa, Balaji, Ganguly, Bishwa, Chao, Debra, Rice, Audie G, Zhan, Fenghuang, Shaughnessy, Jr, John D, Barlogie, Bart, Yaccoby, Shmuel, Afar, Daniel E H

Volltext

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS von Guo, Wancheng, Zhan, Anne, Mery, David E., Munshi, Manit N., Makhoul, Oussama, Baily, Clyde, Zangari, Maurizio, Tricot, Guido, Peng, Hongling, Shaughnessy, John D.

Volltext

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages von Cheng, Yan, Sun, Fumou, Alapat, Daisy V., Wanchai, Visanu, Mery, David, Siegel, Eric R., Xu, Hongwei, Johnson, Sarah, Guo, Wancheng, Bailey, Clyde, Ashby, Cody, Bauer, Michael Anton, Hadidi, Samer Al, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits, Tricot, Guido, Shaughnessy, John D., Zhan, Fenghuang

Volltext

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis von Brenne, Anne-Tove, Fagerli, Unn-Merete, Shaughnessy Jr, John D., Våtsveen, Thea Kristin, Rø, Torstein Baade, Hella, Hanne, Zhan, Fenghuang, Barlogie, Bart, Sundan, Anders, Børset, Magne, Waage, Anders

Volltext